子宮内膜症に対するグローバルレビューが緊急対応を要請(Global reviews call for urgent action on endometriosis in most world regions)

ad

2025-11-12 オックスフォード大学

イギリスのUniversity of Oxfordが発表した2件のレビュー論文(共に刊行先は The Lancet Obstetrics, Gynaecology & Women’s Health)によると、子宮内膜症は世界的に約10人に1人の女性・少女が経験する慢性炎症疾患である一方、194の加盟国を対象にした調査では、半数近くが診断や治療のための国としての指針を持たず、公式政府承認の臨床ガイドラインを備えている国はわずか7%にとどまることが明らかとなった。臨床ガイドラインの不備は診断遅延や治療格差を生み、患者と医療従事者双方が十分な情報・支援にアクセスできない状況を招いている。また、政策面でも、半数の国で子宮内膜症を対象とした国家的な方針が欠如しており、政策策定・実行において著しい地域格差が存在する。研究者らは、各国政府・医療学会・患者支援団体が協働して、地域に即した診療ガイドラインと国家戦略を構築し、診断から治療まで均等なケア提供を実現することを強く要請している。

<関連情報>

地域特有の子宮内膜症ケアガイダンスの入手可能性:世界的なスコープレビュー Availability of region-specific endometriosis care guidance: a global scoping review

Devon Evans, MD ∙ Tatjana Gibbons, MBBS ∙ Becky Skidmore, MLS ∙ Prof Krina T Zondervan, DPhil ∙ G David Adamson, MD ∙ Prof Linda C Giudice, MD ∙ et al.
The Lancet Obstetrics, Gynaecology & Women’s Health  Published: November 2025
DOI:https://doi.org/10.1016/j.lanogw.2025.100004

子宮内膜症に対するグローバルレビューが緊急対応を要請(Global reviews call for urgent action on endometriosis in most world regions)

Summary

Guidance on standards of care, particularly incorporating region-specific needs, is foundational to high-quality health care. The availability of region-specific guidance on endometriosis care, particularly in low-income and middle-income countries, has not previously been documented. We conducted a scoping review of endometriosis care guidance in each of the 194 WHO member states to identify the highest organisational level of guidance by region. Nine sources were defined, ranging from national society and government documents to news and social media posts. There is geographical heterogeneity in the existence and sources of guidance, with the greatest availability in Europe. In regions where national societies or advocacy groups exist, many do not maintain or reference care guidelines—even when they exist locally. To ensure patients, providers, and policy makers have access to endometriosis care guidance, patient advocacy groups, professional societies, and governments need to create, maintain, and publicise their resources for patients and providers.

 

子宮内膜症政策と提供システム:包括的な世界規模のスコープレビュー Endometriosis policy and delivery systems: a comprehensive global scoping review

Tatjana Gibbons, MBBS ∙ Devon Evans, MD ∙ Becky Skidmore, MLS ∙ Prof Christian M Becker, MD ∙ Prof Stacey A Missmer, SCD ∙ Prof Linda C Giudice, MD ∙ et al.
The Lancet Obstetrics, Gynaecology & Women’s Health  Published: November 2025
DOI:https://doi.org/10.1016/j.lanogw.2025.100027

Summary

Despite the prevalence and socioeconomic impact of endometriosis, it is under-represented in global health policy. To our knowledge, this scoping review is the first to comprehensively map the availability of global endometriosis policies. The 477 included documents identified three frameworks and one approach used by countries to develop and operationalise endometriosis policies and initiatives: (1) stand-alone endometriosis national action plans (NAPs); (2) integration of endometriosis policy and initiatives into other health NAPs; (3) stand-alone endometriosis laws; and (4) ad-hoc initiatives. A thematic analysis enabled the aggregation of global endometriosis policies and initiatives within the WHO health system building blocks. Further analysis revealed the maturity of countries’ policy development. No information could be detected for 98 countries. However, 48 countries were raising awareness of endometriosis as a national problem, 36 countries had placed endometriosis on the political agenda, eight were adopting policies for a national endometriosis strategy, and four were implementing and evaluating strategies. Despite the global scarcity of endometriosis policy framework documents, this Review highlights promising examples, most notably Australia’s and France’s endometriosis NAP, which could be adapted by countries seeking to advance their endometriosis policies.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました